Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 10, 2025 Filed Apr 11, 2025 16:15 UTC |
Sassi NirChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 41 | $0.07 Strike: $331.20 | $2.91 |
DisclosureSEC source: 0001641172-25-003826 · ownership.xml · derivative · entry 6 Sassi Nir · CIK 0001760673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41 shares Expires 2026-03-27 F1 · price: The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 16:15 UTC |
Sassi NirChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 500 | $0.07 Strike: $357.28 | $35.50 |
DisclosureSEC source: 0001641172-25-003826 · ownership.xml · derivative · entry 5 Sassi Nir · CIK 0001760673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2026-07-25 F1 · price: The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 16:15 UTC |
Sassi NirChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 500 | $0.07 Strike: $357.28 | $35.50 |
DisclosureSEC source: 0001641172-25-003826 · ownership.xml · derivative · entry 4 Sassi Nir · CIK 0001760673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2026-07-25 F1 · price: The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 16:15 UTC |
Sassi NirChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,500 | $0.07 Strike: $72.00 | $177.50 |
DisclosureSEC source: 0001641172-25-003826 · ownership.xml · derivative · entry 3 Sassi Nir · CIK 0001760673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2026-09-13 F1 · price: The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 16:15 UTC |
Sassi NirChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,125 | $0.07 Strike: $34.32 | $79.88 |
DisclosureSEC source: 0001641172-25-003826 · ownership.xml · derivative · entry 2 Sassi Nir · CIK 0001760673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,125 shares Expires 2027-02-17 F1 · price: The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 16:15 UTC |
Sassi NirChief Financial Officer
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,250 | $0.07 Strike: $25.72 | $88.75 |
DisclosureSEC source: 0001641172-25-003826 · ownership.xml · derivative · entry 1 Sassi Nir · CIK 0001760673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,250 shares Expires 2027-09-16 F1 · price: The options were canceled by mutual agreement of the reporting person and Indaptus Therapeutics, Inc. The reporting person received $500 total as consideration for the cancellation. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 21:12 UTC |
Meckler Jeffrey ADirector · CEO and Director
|
GrantCommon Stock Warrants · Derivative | 42,553 | $1.18 Strike: $1.05 | $49,999.78 |
DisclosureSEC source: 0001493152-24-047808 · ownership.xml · derivative · entry 2 Meckler Jeffrey A · CIK 0001506916 · Director · CEO and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,553 Underlying: Common Stock · 42,553 shares Expires 2029-11-25 F1 · price: The Reporting Person acquired 42,553 shares of common stock and 42,553 warrants to purchase common stock from the Issuer for an aggregate purchase price of $49,999.78. F1 · derivative.exercise_date: The Reporting Person acquired 42,553 shares of common stock and 42,553 warrants to purchase common stock from the Issuer for an aggregate purchase price of $49,999.78. Read SEC document |
| November 25, 2024 Filed Nov 26, 2024 21:12 UTC |
Meckler Jeffrey ADirector · CEO and Director
|
GrantCommon stock | 42,553 | $1.18 | $49,999.78 |
DisclosureSEC source: 0001493152-24-047808 · ownership.xml · nonDerivative · entry 1 Meckler Jeffrey A · CIK 0001506916 · Director · CEO and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,859 F1 · price: The Reporting Person acquired 42,553 shares of common stock and 42,553 warrants to purchase common stock from the Issuer for an aggregate purchase price of $49,999.78. Read SEC document |
| October 09, 2024 Filed Oct 10, 2024 16:05 UTC |
Newman Michael JamesDirector · CSO and Director · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001493152-24-040730 · ownership.xml · derivative · entry 1 Newman Michael James · CIK 0001876315 · Director · CSO and Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-10-09 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| October 09, 2024 Filed Oct 10, 2024 20:05 UTC |
Meckler Jeffrey ADirector · CEO and Director
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001493152-24-040726 · ownership.xml · derivative · entry 1 Meckler Jeffrey A · CIK 0001506916 · Director · CEO and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-10-09 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| October 09, 2024 Filed Oct 10, 2024 16:05 UTC |
Linscott Walt AddisonChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001493152-24-040727 · ownership.xml · derivative · entry 1 Linscott Walt Addison · CIK 0001648585 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-10-09 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| October 09, 2024 Filed Oct 10, 2024 16:05 UTC |
Waltzman Roger J.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001493152-24-040728 · ownership.xml · derivative · entry 1 Waltzman Roger J. · CIK 0001678987 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-10-09 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| October 09, 2024 Filed Oct 10, 2024 16:05 UTC |
Sassi NirChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.11 | $0.00 |
DisclosureSEC source: 0001493152-24-040729 · ownership.xml · derivative · entry 1 Sassi Nir · CIK 0001760673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-10-09 F1 · derivative.exercise_date: The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date. Read SEC document |
| August 08, 2024 Filed Aug 8, 2024 21:30 UTC |
Meckler Jeffrey ADirector · CEO and Director
|
GrantCommon Stock Warrants · Derivative | 84,932 | $1.83 Strike: $1.70 | $155,000.90 |
DisclosureSEC source: 0001493152-24-030839 · ownership.xml · derivative · entry 2 Meckler Jeffrey A · CIK 0001506916 · Director · CEO and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,932 Underlying: Common Stock · 84,932 shares Expires 2029-08-08 F1 · price: The Reporting Person acquired 84,932 shares of common stock and 84,932 warrants to purchase common stock from the Issuer for an aggregate purchase price of $155,000.90. F1 · derivative.exercise_date: The Reporting Person acquired 84,932 shares of common stock and 84,932 warrants to purchase common stock from the Issuer for an aggregate purchase price of $155,000.90. Read SEC document |
| August 08, 2024 Filed Aug 8, 2024 21:30 UTC |
Meckler Jeffrey ADirector · CEO and Director
|
GrantCommon stock | 84,932 | $1.83 | $155,000.90 |
DisclosureSEC source: 0001493152-24-030839 · ownership.xml · nonDerivative · entry 1 Meckler Jeffrey A · CIK 0001506916 · Director · CEO and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,306 F1 · price: The Reporting Person acquired 84,932 shares of common stock and 84,932 warrants to purchase common stock from the Issuer for an aggregate purchase price of $155,000.90. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 17:00 UTC |
Karah HilaDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001493152-24-023152 · ownership.xml · derivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-06-06 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on June 6, 2025. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 21:00 UTC |
Hayes William BDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001493152-24-023151 · ownership.xml · derivative · entry 1 Hayes William B · CIK 0001320940 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-06-06 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on June 6, 2025. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 17:00 UTC |
Martell RobertDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001493152-24-023150 · ownership.xml · derivative · entry 1 Martell Robert · CIK 0001529922 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-06-06 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on June 6, 2025. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 17:00 UTC |
MADDALUNA ANTHONY JDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001493152-24-023148 · ownership.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-06-06 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on June 6, 2025. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 21:00 UTC |
Pomerantz RogerDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001493152-24-023149 · ownership.xml · derivative · entry 1 Pomerantz Roger · CIK 0001614936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-06-06 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on June 6, 2025. Read SEC document |
| June 06, 2024 Filed Jun 7, 2024 21:00 UTC |
Gilbert Mark JohnDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001493152-24-023147 · ownership.xml · derivative · entry 1 Gilbert Mark John · CIK 0001897698 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2034-06-06 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on June 6, 2025. Read SEC document |
| January 22, 2024 Filed Jan 23, 2024 16:15 UTC |
Newman Michael JamesDirector · CSO and Director · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 43,250 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001493152-24-003447 · ownership.xml · derivative · entry 1 Newman Michael James · CIK 0001876315 · Director · CSO and Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,250 Underlying: Common Stock · 43,250 shares Expires 2034-01-22 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027. Read SEC document |
| January 22, 2024 Filed Jan 23, 2024 21:15 UTC |
Meckler Jeffrey ADirector · CEO and Director
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001493152-24-003450 · ownership.xml · derivative · entry 1 Meckler Jeffrey A · CIK 0001506916 · Director · CEO and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-01-22 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027. Read SEC document |
| January 22, 2024 Filed Jan 23, 2024 16:15 UTC |
Linscott Walt AddisonChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001493152-24-003451 · ownership.xml · derivative · entry 1 Linscott Walt Addison · CIK 0001648585 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-01-22 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027. Read SEC document |
| January 22, 2024 Filed Jan 23, 2024 16:15 UTC |
Waltzman Roger J.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001493152-24-003449 · ownership.xml · derivative · entry 1 Waltzman Roger J. · CIK 0001678987 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2034-01-22 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027. Read SEC document |
| January 22, 2024 Filed Jan 23, 2024 16:15 UTC |
Sassi NirChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.74 | $0.00 |
DisclosureSEC source: 0001493152-24-003445 · ownership.xml · derivative · entry 1 Sassi Nir · CIK 0001760673 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2034-01-22 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027. Read SEC document |
| August 14, 2023 Filed Aug 16, 2023 18:01 UTC |
Anderson Glen R.10% owner
|
PurchaseCommon Stock | 23,934 | $2.34 | $56,005.56 |
DisclosureSEC source: 0001493152-23-029212 · ownership.xml · nonDerivative · entry 3 Anderson Glen R. · CIK 0001878961 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Anderson Family Trust u/a dtd 01/07/2018 Disclosed balance after: 1,190,400 Read SEC document |
| August 11, 2023 Filed Aug 16, 2023 18:01 UTC |
Anderson Glen R.10% owner
|
PurchaseCommon Stock | 35,064 | $2.12 | $74,335.68 |
DisclosureSEC source: 0001493152-23-029212 · ownership.xml · nonDerivative · entry 2 Anderson Glen R. · CIK 0001878961 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Anderson Family Trust u/a dtd 01/07/2018 Disclosed balance after: 1,166,466 Read SEC document |
| August 10, 2023 Filed Aug 16, 2023 18:01 UTC |
Anderson Glen R.10% owner
|
PurchaseCommon Stock | 44,354 | $1.94 | $86,046.76 |
DisclosureSEC source: 0001493152-23-029212 · ownership.xml · nonDerivative · entry 1 Anderson Glen R. · CIK 0001878961 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Anderson Family Trust u/a dtd 01/07/2018 Disclosed balance after: 1,131,402 Read SEC document |
| August 07, 2023 Filed Aug 7, 2023 17:25 UTC |
Waltzman Roger J.Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 90,000 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001493152-23-027061 · ownership.xml · derivative · entry 1 Waltzman Roger J. · CIK 0001678987 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2033-08-07 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on August 7, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on August 7, 2026. Read SEC document |
| May 25, 2023 Filed May 30, 2023 16:15 UTC |
Karah HilaDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001493152-23-019462 · ownership.xml · derivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-05-25 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on May 25, 2024. Read SEC document |
| May 25, 2023 Filed May 30, 2023 20:15 UTC |
Hayes William BDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001493152-23-019463 · ownership.xml · derivative · entry 1 Hayes William B · CIK 0001320940 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-05-25 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on May 25, 2024. Read SEC document |
| May 25, 2023 Filed May 30, 2023 16:15 UTC |
MADDALUNA ANTHONY JDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001493152-23-019459 · ownership.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-05-25 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on May 25, 2024. Read SEC document |
| May 25, 2023 Filed May 30, 2023 20:15 UTC |
Pomerantz RogerDirector
|
GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001493152-23-019460 · ownership.xml · derivative · entry 1 Pomerantz Roger · CIK 0001614936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-25 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on May 25, 2024. Read SEC document |
| May 25, 2023 Filed May 30, 2023 20:15 UTC |
Gilbert Mark JohnDirector
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $1.82 | $0.00 |
DisclosureSEC source: 0001493152-23-019461 · ownership.xml · derivative · entry 1 Gilbert Mark John · CIK 0001897698 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2033-05-25 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on May 25, 2024. Read SEC document |
| February 13, 2023 Filed Feb 14, 2023 17:58 UTC |
Martell RobertDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001493152-23-005058 · ownership.xml · derivative · entry 1 Martell Robert · CIK 0001529922 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-02-13 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on February 13, 2024. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 16:05 UTC |
Newman Michael JamesDirector · CSO and Director · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 43,250 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001493152-23-002019 · ownership.xml · derivative · entry 1 Newman Michael James · CIK 0001876315 · Director · CSO and Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,250 Underlying: Common Stock · 43,250 shares Expires 2033-01-18 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 21:05 UTC |
Meckler Jeffrey ADirector · CEO and Director
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001493152-23-002021 · ownership.xml · derivative · entry 1 Meckler Jeffrey A · CIK 0001506916 · Director · CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2033-01-18 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 16:05 UTC |
Linscott Walt AddisonChief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001493152-23-002023 · ownership.xml · derivative · entry 1 Linscott Walt Addison · CIK 0001648585 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-01-18 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 16:05 UTC |
Sassi NirChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.61 | $0.00 |
DisclosureSEC source: 0001493152-23-002020 · ownership.xml · derivative · entry 1 Sassi Nir · CIK 0001760673 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2033-01-18 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-third of the total shares on January 18, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 18, 2026. Read SEC document |
| December 01, 2022 Filed Dec 20, 2022 02:06 UTC |
Litchev Boyan VesselinovChief Medical Officer
|
PurchaseCommon Stock | 500 | $1.87 | $935.45 |
DisclosureSEC source: 0001493152-22-035926 · ownership.xml · nonDerivative · entry 4 Litchev Boyan Vesselinov · CIK 0001902726 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150 Read SEC document |
| November 22, 2022 Filed Dec 20, 2022 02:06 UTC |
Litchev Boyan VesselinovChief Medical Officer
|
PurchaseCommon Stock | 500 | $1.83 | $915.00 |
DisclosureSEC source: 0001493152-22-035926 · ownership.xml · nonDerivative · entry 3 Litchev Boyan Vesselinov · CIK 0001902726 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650 Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 13:00 UTC |
Meckler Jeffrey ADirector · CEO and Director
|
PurchaseCommon stock | 9,600 | $1.90 | $18,240.00 |
DisclosureSEC source: 0001493152-22-033241 · ownership.xml · nonDerivative · entry 2 Meckler Jeffrey A · CIK 0001506916 · Director · CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,374 Read SEC document |
| November 18, 2022 Filed Nov 22, 2022 13:00 UTC |
Meckler Jeffrey ADirector · CEO and Director
|
PurchaseCommon stock | 400 | $1.76 | $705.48 |
DisclosureSEC source: 0001493152-22-033241 · ownership.xml · nonDerivative · entry 1 Meckler Jeffrey A · CIK 0001506916 · Director · CEO and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,774 Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 16:31 UTC |
Karah HilaDirector
|
GrantStock Option (right to buy) · Derivative | 13,750 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001493152-22-027441 · ownership.xml · derivative · entry 1 Karah Hila · CIK 0001668116 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2032-09-30 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on September 30, 2023. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:30 UTC |
O'CALLAGHAN BRIANDirector
|
GrantStock Option (right to buy) · Derivative | 13,750 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001493152-22-027434 · ownership.xml · derivative · entry 1 O'CALLAGHAN BRIAN · CIK 0001415015 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2032-09-30 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on September 30, 2023. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:30 UTC |
Hayes William BDirector
|
GrantStock Option (right to buy) · Derivative | 13,750 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001493152-22-027431 · ownership.xml · derivative · entry 1 Hayes William B · CIK 0001320940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2032-09-30 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on September 30, 2023. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:30 UTC |
Pomerantz RogerDirector
|
GrantStock Option (right to buy) · Derivative | 81,000 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001493152-22-027438 · ownership.xml · derivative · entry 1 Pomerantz Roger · CIK 0001614936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,000 Underlying: Common Stock · 81,000 shares Expires 2032-09-30 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to one-half of the total shares on September 30, 2023 and thereafter the remaining shares vest and become exercisable on September 30, 2024. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 16:30 UTC |
MADDALUNA ANTHONY JDirector
|
GrantStock Option (right to buy) · Derivative | 13,750 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001493152-22-027432 · ownership.xml · derivative · entry 1 MADDALUNA ANTHONY J · CIK 0001566333 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2032-09-30 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on September 30, 2023. Read SEC document |
| September 30, 2022 Filed Oct 3, 2022 20:30 UTC |
Gilbert Mark JohnDirector
|
GrantStock Option (right to buy) · Derivative | 13,750 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001493152-22-027439 · ownership.xml · derivative · entry 1 Gilbert Mark John · CIK 0001897698 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Underlying: Common Stock · 13,750 shares Expires 2032-09-30 F1 · derivative.exercise_date: The stock option vests and becomes exercisable on September 30, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.